The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Survival among women with borderline ovarian tumors and ovarian carcinoma: A population‐based analysis
Abstract
BACKGROUND: Serous and mucinous ovarian tumors of low malignant potential (LMP‐S and LMP‐M, respectively) are noninvasive tumors that portend excellent survival when confined to the ovary. Comparison of the survival for women with LMP tumors staged as distant with women who have carcinoma may have important implications for diagnostic terminology and clinical management. METHODS: The authors compared relative survival rates among patients diagnosed with ovarian tumors during the period 1988–1999 (with follow‐up through 2000) by histologic type, disease stage, tumor grade (for carcinomas), and patient age, using data from the Surveillance, Epidemiology, and End Results Program. RESULTS: The overall relative survival rate at 10 years (± 1.96 standard errors) was 96.9% ± 2.3% for women with LMP‐S tumors, 30.4% ± 1.7% for women with serous carcinoma (CA‐S); 94.0% ± 3.1% for women with LMP‐M tumors, and 64.7% ± 3.4% for women with mucinous carcinoma (CA‐M). The survival rate at 10 years for women with distant‐stage LMP‐S tumors was 89.9% ± 5.3%, compared with 96.1% ± 8.6% for women with well differentiated, localized CA‐S. The survival rate for women with distant‐stage LMP‐M tumors at 5 years was 85.5% ± 9.0%, compared with 95.5% ± 3.4% for women with well differentiated, localized CA‐M (data for 10 years were limited). Mucinous ovarian neoplasms were associated with an excess of second malignancies of the digestive tract. CONCLUSIONS: Relative survival among women with distant‐stage LMP tumors was not 100% and resembled the survival of women who had carcinoma exhibiting favorable prognostic features (localized stage). Future studies of women with high‐stage LMP tumors are required to clarify the pathogenesis of extraovarian lesions and their implications for management and prognosis. Cancer 2004;100:1045–52. Published 2004 by the American Cancer Society.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Use of proteomic patterns in serum to identify ovarian cancer
Petricoin, E. F., Ardekani, A. M., Hitt, B. A., Levine, P. J., Fusaro, V. A., Steinberg, S. M., Mills, G. B., Simone, C., Fishman, D. A., Kohn, E. C., et al. (2002) · The Lancet · doi:10.1016/s0140-6736(02)07746-2 · Cited by 3,236
Cited by
Menon, U., Gentry-Maharaj, A., Hallett, R., Ryan, A., Burnell, M., Sharma, A., Lewis, S., Davies, S., Philpott, S., Lopes, A., et al. (2009) · The Lancet Oncology · doi:10.1016/s1470-2045(09)70026-9 · Cited by 829
Neutrophils facilitate ovarian cancer premetastatic niche formation in the omentum
Lee, W., Ko, S. Y., Mohamed, M. S., Kenny, H. A., Lengyel, E., & Naora, H. (2019) · Journal of Experimental Medicine · doi:10.1084/jem.20181170 · Cited by 478
Diagnosis, Treatment, and Follow-Up of Borderline Ovarian Tumors
Fischerova, D., Zikan, M., Dundr, P., & Cibula, D. (2012) · The Oncologist · doi:10.1634/theoncologist.2012-0139 · Cited by 279
Ovarian borderline tumors in the 2014 WHO classification: evolving concepts and diagnostic criteria
Hauptmann, S., Friedrich, K., Redline, R., & Avril, S. (2017) · Virchows Archiv · doi:10.1007/s00428-016-2040-8 · Cited by 270
Metadata
- Authors
- Sherman, M. E., Mink, P. J., Curtis, R., Cote, T. R., Brooks, S., Hartge, P., & Devesa, S.
- Venue
- Cancer
- Publisher
- Wiley
- Published
- 2004-01-30
- Volume
- 100
- Issue
- 5
- Pages
- 1045-1052
- ISSN
- 0008-543X (ISSN-L)
- 1097-0142
- OpenAlex
- W2053292861
- Cited by
- 179
- References
- 1
- FWCI
- 10.40
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.